Cargando...
Inhibition of FGF‐FGFR and VEGF‐VEGFR signalling in cancer treatment
The sites of targeted therapy are limited and need to be expanded. The FGF‐FGFR signalling plays pivotal roles in the oncogenic process, and FGF/FGFR inhibitors are a promising method to treat FGFR‐altered tumours. The VEGF‐VEGFR signalling is the most crucial pathway to induce angiogenesis, and inh...
Guardado en:
| Publicado en: | Cell Prolif |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8016646/ https://ncbi.nlm.nih.gov/pubmed/33655556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.13009 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|